A detailed history of Black Rock Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,533,442 shares of DAWN stock, worth $61.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,533,442
Previous 5,031,435 9.9%
Holding current value
$61.7 Million
Previous $83.1 Million 24.84%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.03 - $17.69 $5.99 Million - $8.81 Million
-497,993 Reduced 9.9%
4,533,442 $62.5 Million
Q1 2024

May 10, 2024

SELL
$13.56 - $17.46 $1.28 Million - $1.65 Million
-94,636 Reduced 1.85%
5,031,435 $83.1 Million
Q4 2023

Feb 13, 2024

BUY
$9.68 - $15.37 $4.24 Million - $6.73 Million
437,637 Added 9.33%
5,126,071 $74.8 Million
Q3 2023

Nov 13, 2023

BUY
$11.22 - $14.86 $12.6 Million - $16.7 Million
1,123,701 Added 31.52%
4,688,434 $57.5 Million
Q2 2023

Aug 11, 2023

BUY
$11.74 - $14.47 $15.3 Million - $18.9 Million
1,306,238 Added 57.84%
3,564,733 $42.6 Million
Q1 2023

May 12, 2023

SELL
$12.75 - $23.41 $2.25 Million - $4.14 Million
-176,773 Reduced 7.26%
2,258,495 $30.2 Million
Q4 2022

Feb 13, 2023

SELL
$18.77 - $22.0 $1.99 Million - $2.33 Million
-105,967 Reduced 4.17%
2,435,268 $52.4 Million
Q3 2022

Nov 14, 2022

BUY
$16.44 - $26.57 $9.51 Million - $15.4 Million
578,511 Added 29.47%
2,541,235 $50.9 Million
Q2 2022

Aug 12, 2022

BUY
$5.72 - $17.9 $4.57 Million - $14.3 Million
799,808 Added 68.78%
1,962,724 $35.1 Million
Q1 2022

May 12, 2022

BUY
$9.12 - $17.47 $3.75 Million - $7.18 Million
410,797 Added 54.62%
1,162,916 $11.5 Million
Q4 2021

Feb 10, 2022

BUY
$15.65 - $26.33 $3.61 Million - $6.08 Million
230,846 Added 44.29%
752,119 $12.7 Million
Q3 2021

Nov 09, 2021

BUY
$20.0 - $27.92 $10.3 Million - $14.4 Million
516,901 Added 11822.99%
521,273 $12.4 Million
Q2 2021

Aug 11, 2021

BUY
$19.0 - $23.69 $83,068 - $103,572
4,372 New
4,372 $99,000

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.